Additionally, the co-expression of S100B and AHR in IBS-D patients differed from that in controls and was associated with IBS-SSS, intestinal barrier function, visceral hypersensitivity, and intestinal inflammation. This evidence concerns the gene S100B and irritable bowel syndrome.